Topical treatment against adenoviral infection
|Organization:||University of Pittsburgh, Pa, US|
|I.P. Brief:||The inventors have discovered a new use for the compound Iv-IgG. When administered topically, this drug is effective in the treatment of Epidemic Keratoconjunctivis (EKC). Used opthalmically, these preparations have demonstrated the elimination of the infection, reduction of viral shedding and a decreased transmission of the virus.|
|Keywords:||therapeutic , anti-viral, keratoconjuncitivits, opthalmic|
|Primary Industry:||Pharma & Biotech|
|Specific Market:||drug companies focused on infectious diseases|
Full IP Descriptions available on-site.